To Evaluate the Patient Tolerance, Pharmacodynamics and Pharmacokinetics of Lanthanum Polystyrene Sulfonate Powder

NCT04440696 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyperphosphatemia

Interventions

DRUG: Lanthanum Polystyrene Sulphonate Powder
DRUG: Lanthanum Carbonate 500 MG
DRUG: Placebo

Sponsor

Grand Life Science (Liaoning) Co., Ltd.

Collaborators

[object Object]